Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Journal of the American College of Cardiology|May 16, 2006
Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentanRobyn J Barst, David Langleben, David Badesch, et al.Pulmonary Circulation|November 4, 2021
Survival and drug persistence in patients receiving inhaled treprostinil at doses greater than 54 µg (nine breaths) four times dailyShelley Shapiro, Stacy Mandras, Ricardo Restrepo-Jaramillo, et al.Respiratory Medicine|April 22, 2017
Clinical and hemodynamic improvements after adding ambrisentan to background PDE5i therapy in patients with pulmonary arterial hypertension exhibiting a suboptimal therapeutic response (ATHENA-1)Shelley Shapiro, Fernando Torres, Jeremy Feldman, et al.Journal of Cardiovascular Electrophysiology|June 28, 2012
Catheter ablation of typical atrial flutter in severe pulmonary hypertensionJason Bradfield, Shelley Shapiro, William Finch, et al.American Journal of Respiratory and Critical Care Medicine|November 12, 2021
Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE TrialSteven D Nathan, Victor F Tapson, Jean Elwing, et al.Pulmonary Circulation|July 10, 2014
Study design and rationale for investigating phosphodiesterase type 5 inhibition for the treatment of pulmonary hypertension due to chronic obstructive lung disease: the TADA-PHiLD (TADAlafil for Pulmonary Hypertension associated with chronic obstructive Lung Disease) trialBradley A Maron, Ronald H Goldstein, Sharon I Rounds, et al.Pulmonary Pharmacology & Therapeutics|November 15, 2023
Tyvaso DPI: Drug-device characteristics and patient clinical considerationsColleen McEvoy, Rahul Argula, Sandeep Sahay, et al.American Journal of Respiratory and Critical Care Medicine|June 29, 2010
Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapyHossein A Ghofrani, Nicholas W Morrell, Marius M Hoeper, et al.Journal of the American College of Cardiology|August 2, 2005
Ambrisentan therapy for pulmonary arterial hypertensionNazzareno Galié, David Badesch, Ronald Oudiz, et al.Circulation|May 28, 2009
Tadalafil therapy for pulmonary arterial hypertensionNazzareno Galiè, Bruce H Brundage, Hossein A Ghofrani, et al.Pageof 4